Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma von Grivas, Petros, Kopyltsov, Evgeny, Su, Po-Jung, Parnis, Francis X., Park, Se Hoon, Yamamoto, Yoshiaki, Fong, Peter C., Tournigand, Christophe, Climent Duran, Miguel A., Bamias, Aristotelis, Caserta, Claudia, Chang, Jane, Cislo, Paul, di Pietro, Alessandra, Wang, Jing, Powles, Thomas

Volltext

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, doubl... von Tomczak, Piotr, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Gross-Goupil, Marine, Burgents, Joseph E, Xu, Lei, Imai, Kentaro, Choueiri, Toni K, Venugopal, Balaji, Lin, Tzu-Ping, Symeonides, Stefan N., Sawrycki, Piotr, Haas, Naomi B., Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Doshi, Gurjyot, Melichar, Bohuslav, Kopyltsov, Evgeniy, Hammers, Hans-Joerg, Menezes, Juliana de Janoski, Winquist, Eric W., Hamzaj, Alketa, Karaszewska, Boguslawa, Lipatov, Oleg N., McDermott, David, Kochuparambil, Samith T., Davis, Ian D., Peltola, Katriina, Sabbatini, Roberto, Shkolnik, Michail I., McCune, Steven, Yeung, Carrie, Laguerre, Brigitte, Fomin, Eugeniy A., Zakharia, Yousef, Yorio, Jeffrey T., Yanez Ruiz, Eduardo, Kimura, Go, Nishimura, Kazuo, Masumori, Naoya, Kato, Haruaki, Sala Gonzalez, Nuria, Chiu, Kun-Yuan, Atkins, Michael B., Heath, Elisabeth, Feyerabend, Susan, Numakura, Kazuyuki, Zukov, Ruslan, Maroto Rey, Pablo Jose, Chang, Chao-Hsiang, Vengalil, Salil, Waddell, Tom S., Hauke, Ralph, Jayram, Gautam, Estay, Angela, Rubiano, Juan Andres, Anai, Satoshi, Tsunemori, Hiroyuki, Sikora-Kupis, Bozena, Gunderson, Elizabeth, Koletsky, Alan, Chen, Kevin, Agrawal, Manish, Parnis, Francis, Barbosa, Fernando Maciel, Faucher, Genevieve, Iqbal, Nayyer, Hanna, Nawar, Ibanez, Carolina, Manneh, Ray, Holeckova, Petra, Ronkainen, Hanna, Abadie-Lacourtoisie, Sophie, Goebell, Peter J., Hoefner, Thomas, Schultze-Seemann, Wolfgang, Yokomizo, Akira, Matsukawa, Yoshihisa, Murakami, Yoji, Kim, Miso, Szczylik, Cezary, Humphreys, Alison C., Kumar, Birendra, Karam, Jose Antonio, Fleming, Mark, Zarba, Juan Jose, Leiva, Viviana E., Antonio Junior, Joao Neif, Rocha, Roberto Odebrecht, Muniz, David, Brust, Leandro, Graham, Jeffrey, Borchiellini, Delphine, McDermott, Ray, Miura, Yuji, Prow, Debra M., Hashemi-Sadraei, Neda, Kendall, Stephan D.

Volltext

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy von Ravaud, Alain, Motzer, Robert J, Pandha, Hardev S, George, Daniel J, Pantuck, Allan J, Patel, Anup, Chang, Yen-Hwa, Escudier, Bernard, Donskov, Frede, Magheli, Ahmed, Carteni, Giacomo, Laguerre, Brigitte, Tomczak, Piotr, Breza, Jan, Gerletti, Paola, Lechuga, Mariajose, Lin, Xun, Martini, Jean-Francois, Ramaswamy, Krishnan, Casey, Michelle, Staehler, Michael, Patard, Jean-Jacques

Volltext

First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study von Wheatley, Duncan A., Berardi, Rossana, Climent Duran, Miguel A., Tomiak, Anna, Greystoke, Alastair P., Joshua, Anthony M., Arkenau, Hendrik-Tobias, Géczi, Lajos, Corbacho, Javier Garciá, Paz-Ares, Luis G., Hussain, Syed A., Petruželka, Lubos, Delmonte, Angelo, Chappey, Colombe, Masters, Joanna C., Michelon, Elisabete, Murphy, Danielle A., Mwewa, Sandrine, Cesari, Rossano, Doger de Spéville, Bernard

Volltext

Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance von Sridhar, Srikala S., Powles, Thomas, Climent Durán, Miguel Á., Park, Se Hoon, Massari, Francesco, Thiery-Vuillemin, Antoine, Valderrama, Begoña P., Ullén, Anders, Tsuchiya, Norihiko, Aragon-Ching, Jeanny B., Gupta, Shilpa, Petrylak, Daniel P., Bellmunt, Joaquim, Wang, Jing, Laliberte, Robert J., di Pietro, Alessandra, Costa, Nuno, Grivas, Petros, Sternberg, Cora N., Loriot, Yohann

Volltext

Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospect... von López-Abad, Alicia, Ramírez Backhaus, Miguel, Server Gómez, Gerardo, Cao Avellaneda, Enrique, Moreno Alarcón, Cristóbal, López Cubillana, Pedro, Yago Giménez, Pablo, de Pablos Rodríguez, Pedro, Juan Fita, María J., Climent Durán, Miguel Á., Guardiola Ruiz, Iris, Vidal Crespo, Natalia, Artés Artés, Miriam, Montoya Chinchilla, Raúl, Moreno Avilés, Juan, Guzmán Martínez-Valls, Pablo L., López González, Pedro Á.

Volltext

First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study von Lee, Chung-Han, Gurney, Howard, Atduev, Vagif, Suárez, Cristina, Climent Duran, Miguel A, Pook, David William, Tomczak, Piotr, Barthelemy, Philippe, Lee, Jae-Lyun, Nalbandian, Taron, Stus, Viktor, Ferguson, Thomas, Wiechno, Pawel, Gokmen, Erhan, Lacombe, Louis, Gedye, Craig, Burgents, Joseph, Sharma, Manish, Peng, Xiang, Albiges, Laurence

Volltext

Phase I-II study to evaluate safety and efficacy of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial): Preliminary data of phase I st... von Castellano, Daniel E., Duran, Ignacio, Mellado, Begona, Climent Duran, Miguel Angel A., Garcia del Muro, Xavier, Sala González, Nuria, Alonso Gordoa, Teresa, Sevillano, Elena, Domenech, Montserrat, Paramio, Jesus, Real, Francisco X., Malats, Nuria, Sanz, Juan Luis, Font, Albert

Volltext

A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naïve prostate cancer (mHNPC): ZZF... von Mateo, Joaquin, Borque, Ángel, Castellano, Daniel E., Castro, Elena, Climent Duran, Miguel Angel A., Font, Albert, Lorente, David, Mellado, Begona, Rodriguez-Vida, Alejo, Cuadras, Merce, Planas, Jacques, Casanova Salas, Irene, Cordoba, Sarai, Gonzalez, Lucila, Martínez de Falcon, Marta, Fernández, Melissa, Sampayo-Cordero, Miguel, Malfettone, Andrea, Perez-Lopez, Raquel, Carles, Joan

Volltext

Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial von Roubaud, Guilhem, Kostine, Marie, McDermott, Raymond S., Bernard-Tessier, Alice, Maldonado, Xavier, Silva, Marlon, Flechon, Aude, Berthold, Dominik R., Ronchin, Philippe, Tombal, Bertrand F., Mourey, Loic, Gravis, Gwenaelle, Escande, Anne, Abadie Lacourtoisie, Sophie, Thiery-Vuillemin, Antoine, Climent Duran, Miguel Angel A., Ribault, Hélène, Bossi, Alberto, Foulon, Stéphanie, Fizazi, Karim

Volltext

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma von McDermott, David F., Lee, Jae-Lyun, Bjarnason, Georg A., Larkin, James M. G., Gafanov, Rustem A., Kochenderfer, Mark D., Jensen, Niels Viggo, Donskov, Frede, Malik, Jahangeer, Poprach, Alexandr, Tykodi, Scott S., Alonso-Gordoa, Teresa, Cho, Daniel C., Geertsen, Poul F., Climent Duran, Miguel Angel, DiSimone, Christopher, Silverman, Rachel Kloss, Perini, Rodolfo F., Schloss, Charles, Atkins, Michael B.

Volltext

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia von Nadeu, Ferran, Royo, Romina, Massoni-Badosa, Ramon, Playa-Albinyana, Heribert, Garcia-Torre, Beatriz, Duran-Ferrer, Martí, Dawson, Kevin J., Kulis, Marta, Diaz-Navarro, Ander, Villamor, Neus, Melero, Juan L., Chapaprieta, Vicente, Dueso-Barroso, Ana, Delgado, Julio, Moia, Riccardo, Ruiz-Gil, Sara, Marchese, Domenica, Giró, Ariadna, Verdaguer-Dot, Núria, Romo, Mónica, Clot, Guillem, Rozman, Maria, Frigola, Gerard, Rivas-Delgado, Alfredo, Baumann, Tycho, Alcoceba, Miguel, González, Marcos, Climent, Fina, Abrisqueta, Pau, Castellví, Josep, Bosch, Francesc, Aymerich, Marta, Enjuanes, Anna, Ruiz-Gaspà, Sílvia, López-Guillermo, Armando, Jares, Pedro, Beà, Sílvia, Capella-Gutierrez, Salvador, Gelpí, Josep Ll, López-Bigas, Núria, Torrents, David, Campbell, Peter J., Gut, Ivo, Rossi, Davide, Gaidano, Gianluca, Puente, Xose S., Garcia-Roves, Pablo M., Colomer, Dolors, Heyn, Holger, Maura, Francesco, Martín-Subero, José I., Campo, Elías

Volltext

Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management von Bellmunt, Joaquim, Valderrama, Begoña P., Puente, Javier, Grande, Enrique, Bolós, M. Victoria, Lainez, Nuria, Vázquez, Sergio, Maroto, Pablo, Climent, Miguel Ángel, Garcia del Muro, Xavier, Arranz, José Ángel, Durán, Ignacio

Volltext

A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus... von Climent, Miguel A., Font, Albert, Durán, Ignacio, Puente, Javier, José Méndez-Vidal, María, Sáez, María Isabel, Santander Lobera, Carmen, Ángel Arranz Arija, Jóse, González-del-Alba, Aranzazu, Sánchez-Hernandez, Alfredo, Juan Fita, Maria Jose, Esteban, Emilio, Alonso-Gordoa, Teresa, Mellado Gonzalez, Begoña, Maroto, Pablo, Lázaro-Quintela, Martín, Cassinello-Espinosa, Javier, Pérez-Valderrama, Begoña, Garcias, Carmen, Castellano, Daniel

Volltext

PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma von Roldan‐Romero, Juan M., Beuselinck, Benoit, Santos, María, Rodriguez‐Moreno, Juan F., Lanillos, Javier, Calsina, Bruna, Gutierrez, Ana, Tang, Karin, Lainez, Nuria, Puente, Javier, Castellano, Daniel, Esteban, Emilio, Climent, Miguel A., Arranz, Jose A., Albersen, Maarten, Oudard, Stephane, Couchy, Gabrielle, Caleiras, Eduardo, Montero‐Conde, Cristina, Cascón, Alberto, Robledo, Mercedes, Rodríguez‐Antona, Cristina, García‐Donas, Jesús

Volltext

Pilot study to evaluate safety and efficacy of cabozantinib in aged fragile patients with metastatic renal cell carcinoma. Preliminary results of CABOMAYOR-SOGUG study von Climent Duran, Miguel Angel, Sánchez-Escribano, Ricardo, Llabres, Elisenda, Basterretxea, Laura, Torregrosa, Maria Dolores, Guzmán, José Carlos, Zambrana, Francisco, Fernández Núñez, Natalia, Heras, Lucía, Gironés, Regina

Volltext

A phase I-II study to evaluate safety and efficacy of the combination of niraparib plus cabozantinib in patients with advanced kidney/urothelial carcinoma von Font Pous, Albert, Climent Duran, Miguel Angel, Duran, Ignacio, Mellado, Begona, Paramio, Jesus, Real, Francisco X., Ramirez, Jose Luis, Sanz, Juan Luis, Castellano, Daniel E.

Volltext

Expert consensus on the development of quality care measures for kidney cancer in Spain von Guillem, Vicente, Camps, Carlos, Climent Duran, Miguel Angel, Gonzalez del Alba, Aránzazu, Lázaro Quintela, Martín Emilio, Mendez Vidal, María José, Pinto, Alvaro, Puente, Javier, Caballero, Fernando, Campos, Francisco J, Duran, Ignacio, Gallardo Diaz, Enrique

Volltext

BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases von Carbo-Meix, Anna, Guijarro, Francesca, Wang, Luojun, Grau, Marta, Royo, Romina, Frigola, Gerard, Playa-Albinyana, Heribert, Buhler, Marco M, Clot, Guillem, Duran-Ferrer, Marti, Lu, Junyan, Granada, Isabel, Baptista, Maria-Joao, Navarro, Jose-Tomas, Espinet, Blanca, Puiggros, Anna, Tapia, Gustavo, Bandiera, Laura, De Canal, Gabriella, Bonoldi, Emanuela, Climent, Fina, Ribera-Cortada, Inmaculada, Fernandez-Caballero, Mariana, De la Banda, Esmeralda, Do Nascimento, Janilson, Pineda, Alberto, Vela, Dolors, Rozman, Maria, Aymerich, Marta, Syrykh, Charlotte, Brousset, Pierre, Perera, Miguel, Yanez, Lucrecia, Ortin, Jesus Xavier, Tuset, Esperanza, Zenz, Thorsten, Cook, James R, Swerdlow, Steven H, Martin-Subero, Jose I, Colomer, Dolors, Matutes, Estella, Bea, Silvia, Costa, Dolors, Nadeu, Ferran, Campo, Elias

Volltext

Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Geni... von García-del-Muro, Xavier, Durán, Ignacio, Perez-Gracia, Jose Luis, Ángel Climent, Miguel, Mellado, Begoña, Virizuela, Juan A., Castellano, Daniel E., González del Alba, Aranzazu, García Carbonero, Iciar, Álvarez-Fernández, Carlos, García-Donas, Jesús, Gil-Martin, Marta, Hernández, Alvaro-González

Volltext